RelB regulates basal and proinflammatory induction of conjunctival CCL2

REFERENCES

• Hayden MS, Ghosh S. NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012;26(3):203–234. doi:10.1101/gad.183434.111.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Lenardo MJ, Baltimore D. 30 years of nf-κb: a blossoming of relevance to human pathobiology. Cell. 2017;168(1–2):37–57. doi:10.1016/j.cell.2016.12.012.
   PubMed Web of Science ®Google Scholar
• Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 1999;18:6853–6866. doi:10.1038/sj.onc.1203239.
   PubMed Web of Science ®Google Scholar
• Lawrence T. The nuclear factor NF-kB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651. doi:10.1101/cshperspect.a001651.
   PubMed Web of Science ®Google Scholar
• Pomerantz JL, Baltimore D. Two pathways to NF-κB. Mol Cell. 2002;10:693–695.
   PubMed Web of Science ®Google Scholar
• Shih VF, Tsui R, Caldwell A, Hoffmann A. A single NFκB system for both canonical and non-canonical signaling. Cell Res. 2011;21(1):86–102. doi:10.1038/cr.2010.161.
   PubMed Web of Science ®Google Scholar
• Sun SC. The non-canonical NF-κB pathway in immunity and inflammation. Nat Rev Immunol. 2017;17(9):545–558. doi:10.1038/nri.2017.52.
   PubMed Web of Science ®Google Scholar
• Liu TF, Brown CM, El Gazzar M, et al. Fueling the flame: bioenergy couples metabolism and inflammation. J Leukoc Biol. 2012;92(3):499–507.doi:10.1189/jlb.0212078.
   PubMed Web of Science ®Google Scholar
• Millet P, McCall C, Yoza B. RelB: an outlier in leukocyte biology. J Leukoc Biol. 2013;94(5):941–951. doi:10.1189/jlb.0513305.
   PubMed Web of Science ®Google Scholar
• Hitchings RA, Grierson I. Clinico pathological correlation in eyes with failed fistulizing surgery. Trans Ophthalmol Soc UK. 1983;103:84–88.
   PubMedGoogle Scholar
• Seet LF, Finger SN, Chu SW, Toh LZ, Wong TT. Novel insight into the inflammatory and cellular responses following experimental glaucoma surgery: a roadmap for inhibiting fibrosis. Curr Mol Med. 2013;13:911–928.
   PubMed Web of Science ®Google Scholar
• Yamanaka O, Kitano-Izutani A, Tomoyose K, Reinach PS. Pathobiology of wound healing after glaucoma filtration surgery. BMC Ophthalmol. 2015;15(Suppl 1):157. doi:10.1186/s12886-015-0134-8.
   PubMedGoogle Scholar
• Van Bergen T, Van de Velde S, Vandewalle E, Moons L, Stalmans I. Improving patient outcomes following glaucoma surgery: state of the art and future perspectives. Clin Ophthalmol. 2014;8:857–867. doi:10.2147/OPTH.S48745.
   PubMedGoogle Scholar
• Lan W, Petznick A, Heryati S, Rifada M, Tong L. Nuclear Factor-κB: central regulator in ocular surface inflammation and diseases. Ocul Surf. 2012;10(3):137–148. doi:10.1016/j.jtos.2012.04.001.
   PubMed Web of Science ®Google Scholar
• Seet LF, Toh LZ, Finger SN, Chu SWL, Wong TT. Valproic acid exerts specific cellular and molecular anti-inflammatory effects in post-operative conjunctiva. J Mol Med (Berl). 2019;97(1):63–75. doi:10.1007/s00109-018-1722-x.
   PubMed Web of Science ®Google Scholar
• Qian LW, Fourcaudot AB, Yamane K, You T, Chan RK, Leung KP. Exacerbated and prolonged inflammation impairs wound healing and increases scarring. Wound Repair Regen. 2016;24(1):26–34. doi:10.1111/wrr.12381.
   PubMed Web of Science ®Google Scholar
• Hamid T, Guo SZ, Kingery JR, Xiang X, Dawn B, Prabhu SD. Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure. Cardiovasc Res. 2011;89(1):129–138. doi:10.1093/cvr/cvq274.
   PubMed Web of Science ®Google Scholar
• Di Filippo C, Petronella P, Freda F, et al. Involvement of the ubiquitin-proteasome system in the formation of experimental postsurgical peritoneal adhesions. Mediators Inflamm. 2012;2012:194723. doi:10.1155/2012/194723.
   PubMed Web of Science ®Google Scholar
• Ye H, Qian Y, Lin M, et al. Cationic nano-copolymers mediated IKKβ targeting siRNA to modulate wound healing in a monkey model of glaucoma filtration surgery. Mol Vis. 2010;16:2502–2510.
   PubMed Web of Science ®Google Scholar
• Siak JJ, Ng SL, Seet LF, Beuerman RW, Tong L. The nuclear-factor kappaB pathway is activated in pterygium. Invest Ophthalmol Vis Sci. 2011;52(1):230–236. doi:10.1167/iovs.10-5735.
   PubMed Web of Science ®Google Scholar
• Seet LF, Tong L, Su R, Wong TT. Involvement of SPARC and MMP-3 in the pathogenesis of human pterygium. Invest Ophthalmol Vis Sci. 2012;53(2):587–595. doi:10.1167/iovs.11-7941.
   PubMed Web of Science ®Google Scholar
• Wu J, Ding J, Yang J, Guo X, Zheng Y. MicroRNA roles in the nuclear factor kappa B signaling pathway in cancer. Front Immunol. 2018;9:546. doi:10.3389/fimmu.2018.00546.
   PubMed Web of Science ®Google Scholar
• Seet LF, Su R, Barathi VA, et al. SPARC deficiency results in improved surgical survival in a novel mouse model of glaucoma filtration surgery. PLoS One. 2010;5(2):e9415. doi:10.1371/journal.pone.0009415.
   PubMed Web of Science ®Google Scholar
• Yadav A, Saini V, Arora S. MCP-1: chemoattractant with a role beyond immunity: a review. Clin Chim Acta. 2010;411(21–22):1570–1579. doi:10.1016/j.cca.2010.07.006.
   PubMed Web of Science ®Google Scholar
• Seet LF, Su R, Toh LZ, Wong TT. In vitro analyses of the anti-fibrotic effect of SPARC silencing in human Tenon’s fibroblasts: comparisons with mitomycin C. J Cell Mol Med. 2012;16(6):1245–1259. doi:10.1111/j.1582-4934.2011.01400.x.
   PubMed Web of Science ®Google Scholar
• Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data, a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;64:5245–5250. doi:10.1158/0008-5472.CAN-04-0496.
   PubMed Web of Science ®Google Scholar
• Goodpaster T, Legesse-Miller A, Hameed MR, Aisner SC, Randolph-Habecker J, Coller HA. An immunohistochemical method for identifying fibroblasts in formalin-fixed, paraffin-embedded tissue. J Histochem Cytochem. 2008;56(4):347–358. doi:10.1369/jhc.7A7287.2007.
   PubMed Web of Science ®Google Scholar
• Mead AL, Wong TT, Cordeiro MF, Anderson IK, Khaw PT. Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery. Invest Ophthalmol Vis Sci. 2003;44(8):3394–3401. doi:10.1167/iovs.02-0978.
   PubMed Web of Science ®Google Scholar
• Schjerven H, Tran TN, Brandtzaeg P, Johansen FE. De novo synthesized RelB mediates TNF-induced up-regulation of the human polymeric Ig receptor. J Immunol. 2004;173(3):1849–1857. doi:10.4049/jimmunol.173.3.1849.
   PubMed Web of Science ®Google Scholar
• Benedetti G, Fokkelman M, Yan K, et al. The nuclear factor κB family member RelB facilitates apoptosis of renal epithelial cells caused by cisplatin/tumor necrosis factor α synergy by suppressing an epithelial to mesenchymal transition-like phenotypic switch. Mol Pharmacol. 2013;84(1):128–138. doi:10.1124/mol.112.084053.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Hou X, Yin X, et al. TNF induction of NF-κB RelB enhances RANKL-induced osteoclastogenesis by promoting inflammatory macrophage differentiation but also limits it through suppression of NFATc1 expression. PLoS One. 2015;10(8):e0135728. doi:10.1371/journal.pone.0135728.
   PubMed Web of Science ®Google Scholar
• Wood MB, Rios D, Williams IR. TNF-α augments RANKL-dependent intestinal M cell differentiation in enteroid cultures. Am J Physiol Cell Physiol. 2016;311(3):C498–507. doi:10.1152/ajpcell.00108.2016.
   PubMed Web of Science ®Google Scholar
• Roy P, Mukherjee T, Chatterjee B, Vijayaragavan B, Banoth B, Basak S. Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB: p50NFκB pathway. Oncogene. 2017;36(10):1417–1429. doi:10.1038/onc.2016.309.
   PubMed Web of Science ®Google Scholar
• Bren GD, Solan NJ, Miyoshi H, Pennington KN, Pobst LJ, Paya CV. Transcription of the RelB gene is regulated by NF-kappaB. Oncogene. 2001;20(53):7722–7733. doi:10.1038/sj.onc.1204868.
   PubMed Web of Science ®Google Scholar
• Marienfeld R, Berberich-Siebelt F, Berberich I, Denk A, Serfling E, Neumann M. Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-kappaB control. Oncogene. 2001;20(56):8142–8147. doi:10.1038/sj.onc.1204884.
   PubMed Web of Science ®Google Scholar
• Maier HJ, Marienfeld R, Wirth T, Baumann B. Critical role of RelB serine 368 for dimerization and p100 stabilization. J Biol Chem. 2003;278(40):39242–39250. doi:10.1074/jbc.M301521200.
   PubMed Web of Science ®Google Scholar
• Fusco AJ, Savinova OV, Talwar R, Kearns JD, Hoffmann A, Ghosh G. Stabilization of RelB requires multidomain interactions with p100/p52. J Biol Chem. 2008;283(18):12324–12332. doi:10.1074/jbc.M707898200.
   PubMed Web of Science ®Google Scholar
• Lu B, Rutledge BJ, Gu L. Fiorillo J, Lukacs NW, Kunkel SL, et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med. 1998;187(4):601–608. doi:10.1084/jem.187.4.601.
   PubMed Web of Science ®Google Scholar
• Gu L, Tseng SC, Rollins BJ. Monocyte chemoattractant protein-1. Chem Immunol. 1999;72:7–29.
   PubMedGoogle Scholar
• Chong RS, Jiang YZ, Boey PY, et al. Tear cytokine profile in medicated glaucoma patients: effect of monocyte chemoattractant protein 1 on early posttrabeculectomy outcome. Ophthalmology. 2010;117(12):2353–2358. doi:10.1016/j.ophtha.2010.03.064.
   PubMed Web of Science ®Google Scholar
• Chong RS, Lee YS, Chu SWL, Toh LZ, Wong TTL. Inhibition of monocyte chemoattractant protein 1 prevents conjunctival fibrosis in an experimental model of glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 2017;58(9):3432–3439. doi:10.1167/iovs.17-21480.
   PubMed Web of Science ®Google Scholar
• Salcedo R, Ponce ML, Young HA, et al. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood. 2000;96:34–40.
   PubMed Web of Science ®Google Scholar
• Gharaee-Kermani M, Denholm EM, Phan SH. Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem. 1996;271:17779–17784. doi:10.1074/jbc.271.30.17779.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Eckes B, Mauch C, Hartmann K, Krieg T. Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop. J Immunol. 2000;164:6174–6179. doi:10.4049/jimmunol.164.12.6174.
   PubMed Web of Science ®Google Scholar
• Tesch GH. MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol. 2008;294(4):F697–701. doi:10.1152/ajprenal.00016.2008.
   PubMed Web of Science ®Google Scholar
• Rog-Zielinska EA, Norris RA, Kohl P, Markwald R. The living scar - cardiac fibroblasts and the injured heart. Trends Mol Med. 2016;22(2):99–114. doi:10.1016/j.molmed.2015.12.006.
   PubMed Web of Science ®Google Scholar
• Lawrence T, Bebien M, Liu GY, Nizet V, Karin M. IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature. 2005;434(7037):1138–1143. doi:10.1038/nature03491.
   PubMed Web of Science ®Google Scholar
• McCall CE, Yoza B, Liu T, El Gazzar M. Gene-specific epigenetic regulation in serious infections with systemic inflammation. J Innate Immun. 2010;2(5):395–405. doi:10.1159/000314077.
   PubMed Web of Science ®Google Scholar
• Schaafsma W, Zhang X, van Zomeren KC, et al. Long-lasting pro-inflammatory suppression of microglia by LPS-preconditioning is mediated by RelB-dependent epigenetic silencing. Brain Behav Immun. 2015;48:205–221. doi:10.1016/j.bbi.2015.03.013.
   PubMed Web of Science ®Google Scholar
• Yoza BK, Hu JY, Cousart SL, Forrest LM, McCall CE. Induction of RelB participates in endotoxin tolerance. J Immunol. 2006;177(6):4080–4085. doi:10.4049/jimmunol.177.6.4080.
   PubMed Web of Science ®Google Scholar
• Tully JE, Nolin JD, Guala AS, et al. Cooperation between classical and alternative NF-κB pathways regulates proinflammatory responses in epithelial cells. Am J Respir Cell Mol Biol. 2012;47(4):497–508. doi:10.1165/rcmb.2012-0014OC.
   PubMed Web of Science ®Google Scholar
• McMillan DH, Woeller CF, Thatcher TH, et al. Attenuation of inflammatory mediator production by the NF-κB member RelB is mediated by microRNA-146a in lung fibroblasts. Am J Physiol Lung Cell Mol Physiol. 2013;304(11):L774–81. doi:10.1152/ajplung.00352.2012.
   PubMed Web of Science ®Google Scholar
• Zago M, Rico de Souza A, Hecht E, et al. The NF-κB family member RelB regulates microRNA miR-146a to suppress cigarette smoke-induced COX-2 protein expression in lung fibroblasts. Toxicol Lett. 2014;226(2):107–116. doi:10.1016/j.toxlet.2014.01.020.
   PubMed Web of Science ®Google Scholar
• Spinelli SL, Xi X, McMillan DH, et al. Mapracorat, a selective glucocorticoid receptor agonist, upregulates RelB, an anti-inflammatory nuclear factor-kappaB protein, in human ocular cells. Exp Eye Res. 2014;127:290–298. doi:10.1016/j.exer.2014.07.013.
   PubMed Web of Science ®Google Scholar
• Thatcher TH, Maggirwar SB, Baglole CJ, et al. Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor-kappaB component RelB. Am J Pathol. 2007;170(3):855–864. doi:10.2353/ajpath.2007.060391.
   PubMed Web of Science ®Google Scholar
• Baglole CJ, Maggirwar SB, Gasiewicz TA, Thatcher TH, Phipps RP, Sime PJ. The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-kappaB family member RelB. J Biol Chem. 2008;283(43):28944–28957. doi:10.1074/jbc.M800685200.
   PubMed Web of Science ®Google Scholar
• McMillan DH, Baglole CJ, Thatcher TH, Maggirwar S, Sime PJ, Phipps RP. Lung-targeted overexpression of the NF-κB member RelB inhibits cigarette smoke-induced inflammation. Am J Pathol. 2011;179(1):125–133. doi:10.1016/j.ajpath.2011.03.030.
   PubMed Web of Science ®Google Scholar
• Weih F, Carrasco D, Durham SK, et al. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell. 1995;80:331–340. doi:10.1016/0092-8674(95)90416-6.
   PubMed Web of Science ®Google Scholar
• Barton D, HogenEsch H, Weih F. Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis. Eur J Immunol. 2000;30(8):2323–2332. doi:10.1002/1521-4141(2000)30:8<2323::AID-IMMU2323>3.0.CO;2-H.
   PubMed Web of Science ®Google Scholar
• Martucci C, Franchi S, Lattuada D, Panerai AE, Sacerdote P. Differential involvement of RelB in morphine-induced modulation of chemotaxis NO, and cytokine production in murine macrophages and lymphocytes. J Leukoc Biol. 2007;81(1):344–354. doi:10.1189/jlb.0406237.
   PubMed Web of Science ®Google Scholar
• Xia Y, Pauza ME, Feng L, Lo D. RelB regulation of chemokine expression modulates local inflammation. Am J Pathol. 1997;151:375–387.
   PubMed Web of Science ®Google Scholar
• Ozaki K, Hanazawa S, Takeshita A, et al. Interleukin-1 beta and tumor necrosis factor-alpha stimulate synergistically the expression of monocyte chemoattractant protein-1 in fibroblastic cells derived from human periodontal ligament. Oral Microbiol Immunol. 1996;11(2):109–114.
   PubMedGoogle Scholar
• Monti P, Leone BE, Marchesi F, et al. The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity. Cancer Res. 2003;63(21):7451–7461.
   PubMed Web of Science ®Google Scholar
• Chevrel G, Granet C, Miossec P. Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL6 production, NF-kappaB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors. Ann Rheum Dis. 2005;64(9):1257–1262. doi:10.1136/ard.2004.032359.
   PubMed Web of Science ®Google Scholar
• Souza KL, Gurgul-Convey E, Elsner M, Lenzen S. Interaction between pro-inflammatory and anti-inflammatory cytokines in insulin-producing cells. J Endocrinol. 2008;197(1):139–150. doi:10.1677/JOE-07-0638.
   PubMed Web of Science ®Google Scholar
• Ueda A, Ishigatsubo Y, Okubo T, Yoshimura T. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. J Biol Chem. 1997;272(49):31092–31099. doi:10.1074/jbc.272.49.31092.
   PubMed Web of Science ®Google Scholar
• Saccani S, Pantano S, Natoli G. Modulation of NF-kB activity by exchange of dimers. Mol Cell. 2003;11:1563–1574.
   PubMed Web of Science ®Google Scholar
• El Gazzar M, Yoza BK, Hu JY, Cousart SL, McCall CE. Epigenetic silencing of tumor necrosis factor a during endotoxin tolerance. J Biol Chem. 2007;282(37):26857–26864. doi:10.1074/jbc.M704584200.
   PubMed Web of Science ®Google Scholar
• Feng G, Ohmori Y, Chang PL. Production of chemokine CXCL1/KC by okadaic acid through the nuclear factor-kappaB pathway. Carcinogenesis. 2006 Jan;27(1):43–52. Epub 2005 Jul 6. doi:10.1093/carcin/bgi174.
   PubMed Web of Science ®Google Scholar
• Hashiguchi M, Kobayashi A, Kashiwakura Y, et al. NFκB attenuates IL-5 production and upregulates T-box transcription factors in Th2-like T cells. Cytotechnology. 2014 May;66(3):373–382. doi:10.1007/s10616-013-9585-z. Epub 2013 Aug 11.
   PubMed Web of Science ®Google Scholar
• Fu CY, Wang PC, Tsai HJ. Competitive binding between seryl-tRNA synthetase/YY1 complex and NFKB1 at the distal segment results in differential regulation of human vegfa promoter activity during angiogenesis. Nucleic Acids Res. 2017 Mar 17;45(5):2423–2437. doi:10.1093/nar/gkw1187.
   PubMed Web of Science ®Google Scholar
• Desai MA, Gedde SJ, Feuer WJ, Shi W, Chen PP, Parrish RK. Practice preferences for glaucoma surgery: a survey of the American glaucoma society in 2008. Ophthalmic Surg Lasers Imaging. 2011;42:202–208. doi:10.3928/15428877-20110224-04.
   PubMedGoogle Scholar
• Yamamoto T, Sawada A, Mayama C, et al. Collaborative bleb-related infection incidence and treatment study group. the 5-year incidence of bleb-related infection and its risk factors after filtering surgeries with adjunctive mitomycin C: collaborative bleb-related infection incidence and treatment study 2. Ophthalmology. 2014;121(5):1001–1006. doi:10.1016/j.ophtha.2013.11.025.
   PubMed Web of Science ®Google Scholar
• Radcliffe NM. Trabeculectomy revision as a treatment for failed trabeculectomy. Glaucoma Today. 2010;Fall:25–28.
   Google Scholar
• Broadway DC, Grierson I, O’Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. II. the outcome of filtration surgery. Arch Ophthalmol. 1994;112(11):1446–1454. doi:10.1001/archopht.1994.01090230060021.
   PubMedGoogle Scholar
• Breusegem C, Spielberg L, Van Ginderdeuren R, et al. Preoperative nonsteroidal anti-inflammatory drug or steroid and outcomes after trabeculectomy: a randomized controlled trial. Ophthalmology. 2010;117(7):1324–1330. doi:10.1016/j.ophtha.2009.11.038.
   PubMed Web of Science ®Google Scholar